导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.70% | 1351/4773 |
| 近一周 | -1.92% | 3119/5465 |
| 近一月 | -2.98% | 2061/5421 |
| 近一季 | -4.35% | 1797/5231 |
| 近半年 | 2.40% | 1051/4920 |
| 近一年 | 10.49% | 1105/4394 |
| 近两年 | 57.98% | 1292/2954 |
| 近三年 | 26.85% | 1226/2253 |
| 成立以来 | 487.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.22% 2723/4961 |
13.89% 1922/5312 |
- - |
- - |
| 2025 | 28.54% 1475/4813 |
-0.05% 2037/3635 |
4.95% 675/4076 |
19.15% 2178/4524 |
2.83% 832/4813 |
| 2024 | 2.29% 1977/3463 |
-3.29% 1485/2808 |
-2.38% 1182/3014 |
12.73% 2296/3129 |
-3.89% 2400/3463 |
| 2023 | -13.50% 1547/2656 |
0.19% 1750/2280 |
-5.37% 1438/2385 |
-0.59% 428/2515 |
-8.21% 2265/2655 |
| 2022 | -21.60% 1042/2207 |
-12.96% 675/1919 |
6.03% 785/2016 |
-12.33% 694/2113 |
-3.11% 1835/2208 |
| 2021 | -1.62% 813/1822 |
-1.93% 554/1255 |
6.05% 771/1330 |
-5.73% 851/1466 |
0.35% 1128/1822 |
| 2020 | 33.25% 461/1250 |
-7.53% 550/1028 |
13.63% 602/1067 |
12.87% 358/1164 |
12.36% 475/1184 |
| 2019 | 38.22% 311/1092 |
23.02% 565/754 |
2.12% 99/804 |
2.72% 287/850 |
7.12% 484/918 |
| 2018 | -20.71% 197/834 |
- - |
- - |
- - |
-11.08% 249/691 |
| 2017 | 24.58% 124/714 |
- - |
- - |
- - |
- - |
| 2016 | -7.07% 208/605 |
- - |
- - |
- - |
- - |
| 2015 | 5.83% 215/575 |
- - |
- - |
- - |
- - |
| 2014 | 49.12% 90/237 |
- - |
- - |
- - |
- - |
| 2013 | -6.18% 110/186 |
- - |
- - |
- - |
- - |
| 2012 | 7.91% 62/140 |
- - |
- - |
- - |
- - |
| 2011 | -24.11% 71/102 |
- - |
- - |
- - |
- - |
| 2010 | -11.05% 23/58 |
- - |
- - |
- - |
- - |
| 2009 | 92.40% 5/27 |
- - |
- - |
- - |
- - |
| 2008 | -63.44% 17/26 |
- - |
- - |
- - |
- - |
| 2007 | 148.53% 7/22 |
- - |
- - |
- - |
- - |
| 2006 | 135.47% 2/14 |
- - |
- - |
- - |
- - |
| 2005 | -3.61% 8/11 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 长城久泰沪深300指数A VS. 长安沪深300非周期A(740101) |